Article Text

Download PDFPDF
Classification and management of refractory coeliac disease
  1. Alberto Rubio-Tapia,
  2. Joseph A Murray
  1. Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
  1. Correspondence to Dr Joseph A Murray, 200 First Street SW, Rochester, MN 55905, USA; murray.joseph{at}mayo.edu

Footnotes

  • Linked articles 186007

  • Funding This article was supported by the National Institutes of Health (NIH) under Ruth L. Kirschstein National Research Service Award/Training Grant in Gastrointestinal Allergy and Immunology (T32 AI-07047) (to AR-T) and the NIH grant DK-57892 (to JAM).

  • Competing interests Dr Murray is a consultant for ActogeniX Inc., Flamentera Inc., Ironwood Pharmaceuticals, and Alvine Inc. He is also an investigator for ALBA Therapeutics. Dr Rubio-Tapia declares no competing interest.

  • Provenance and peer review Not commissioned; externally peer reviewed

View Full Text

Statistics from Altmetric.com

Footnotes

  • Linked articles 186007

  • Funding This article was supported by the National Institutes of Health (NIH) under Ruth L. Kirschstein National Research Service Award/Training Grant in Gastrointestinal Allergy and Immunology (T32 AI-07047) (to AR-T) and the NIH grant DK-57892 (to JAM).

  • Competing interests Dr Murray is a consultant for ActogeniX Inc., Flamentera Inc., Ironwood Pharmaceuticals, and Alvine Inc. He is also an investigator for ALBA Therapeutics. Dr Rubio-Tapia declares no competing interest.

  • Provenance and peer review Not commissioned; externally peer reviewed

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles